Literature DB >> 20488834

Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis.

José L Lanciego1, Pedro Barroso-Chinea, Alberto J Rico, Lorena Conte-Perales, Lucía Callén, Elvira Roda, Virginia Gómez-Bautista, Iciar P López, Carmen Lluis, José L Labandeira-García, Rafael Franco.   

Abstract

The putative presence of the cannabinoid receptor type 2 (CB(2)-R) in the central nervous system is still a matter of debate. Although first described in peripheral and immune tissues, evidence suggesting the existence of CB(2)-Rs in glial cells and even neurons has been made available more recently. By taking advantage of newly designed CB(2)-R mRNA riboprobes, we have demonstrated by in situ hybridization and PCR the existence of CB2-R transcripts in a variety of brain areas of the primate Macaca fascicularis, including the cerebral cortex and the hippocampus, as well as in the external and internal divisions of the globus pallidus, both pallidal segments showing the highest abundance of CB(2)-R transcripts. In this regard, the presence of the messenger coding CB(2)-Rs within the pallidal complex highlights their consideration as potential targets for the treatment of movement disorders of basal ganglia origin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20488834     DOI: 10.1177/0269881110367732

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  52 in total

1.  Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice.

Authors:  Hai-Ying Zhang; Ming Gao; Qing-Rong Liu; Guo-Hua Bi; Xia Li; Hong-Ju Yang; Eliot L Gardner; Jie Wu; Zheng-Xiong Xi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

2.  Xie2-64, a novel CB2 receptor inverse agonist, reduces cocaine abuse-related behaviors in rodents.

Authors:  Chloe J Jordan; Zhi-Wei Feng; Ewa Galaj; Guo-Hua Bi; Ying Xue; Ying Liang; Terence McGuire; Xiang-Qun Xie; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2020-07-24       Impact factor: 5.250

3.  Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway.

Authors:  Lin Wang; Bing-Jin Liu; Yun Cao; Wei-Qi Xu; Dong-Sheng Sun; Meng-Zhu Li; Fang-Xiao Shi; Man Li; Qing Tian; Jian-Zhi Wang; Xin-Wen Zhou
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

4.  Cannabinoid receptors CB1 and CB2 form functional heteromers in brain.

Authors:  Lucía Callén; Estefanía Moreno; Pedro Barroso-Chinea; David Moreno-Delgado; Antoni Cortés; Josefa Mallol; Vicent Casadó; José Luis Lanciego; Rafael Franco; Carmen Lluis; Enric I Canela; Peter J McCormick
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

5.  Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus.

Authors:  Y Li; J Kim
Journal:  Neuroscience       Date:  2015-10-26       Impact factor: 3.590

Review 6.  Brain cannabinoid receptor 2: expression, function and modulation.

Authors:  De-Jie Chen; Ming Gao; Fen-Fei Gao; Quan-Xi Su; Jie Wu
Journal:  Acta Pharmacol Sin       Date:  2017-01-09       Impact factor: 6.150

7.  Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.

Authors:  María Gómez-Cañas; Gemma Navarro; Paula Morales; Dow P Hurst; Francisco J Carrillo-Salinas; Laura Lagartera; Ruth Pazos; Pilar Goya; Patricia H Reggio; Carmen Guaza; Rafael Franco; Javier Fernández-Ruiz; Nadine Jagerovic
Journal:  J Med Chem       Date:  2016-07-06       Impact factor: 7.446

Review 8.  CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity.

Authors:  Emmanuel S Onaivi; Hiroki Ishiguro; Shanzhi Gu; Qing-Rong Liu
Journal:  J Psychopharmacol       Date:  2011-03-29       Impact factor: 4.153

Review 9.  Endocannabinoid Signaling in the Central Amygdala and Bed Nucleus of the Stria Terminalis: Implications for the Pathophysiology and Treatment of Alcohol Use Disorder.

Authors:  Gaurav Bedse; Samuel W Centanni; Danny G Winder; Sachin Patel
Journal:  Alcohol Clin Exp Res       Date:  2019-08-21       Impact factor: 3.455

Review 10.  Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.

Authors:  Ewa Galaj; Zheng-Xiong Xi
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.